no statement of use filed
on 01 Jul 2019
Last Applicant/ Owned by
1275 York Avenue
New York
NY
10065
Serial Number
86613157 filed on 28th Apr 2015
Registration Number
N/A
Correspondent Address
ELIZABETH A. WALKER
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations and substances for diagnosis and targeted treatment of cancer and tumor diseases; pharmaceutical preparations and substances for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, deRead More
Pharmaceutical preparations and substances for diagnosis and targeted treatment of cancer and tumor diseases; pharmaceutical preparations and substances for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic agents for diagnosis and targeted treatment of cancer and tumor diseases; therapeutic agents for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic pharmaceuticals and substances for the diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for diagnosis and treatment of diseases and disorders; therapeutic agents for diagnosis and treatment of diseases and disorders
Research and development in the fields of pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; research and development in the field of targeted therapies for cancer and tumor diseases; research and development in the field of targeted therapies for viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; consulting services in the field of scientific research; consulting services in the field of research and development for pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; consulting services in the field of clinical trials; testing, inspection, research, or development of pharmaceutical and therapeutic preparations; pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic product evaluation; conducting early evaluations in the field of new pharmaceuticals and therapeutics; conducting quality control testing, feasibility testing, toxicology testing and pharmacology testing for pharmaceuticals and therapeutics; laboratory research services relating to pharmaceuticals and therapeutics; medical and scientific research, namely, conducting clinical trials for others; product safety testing for pharmaceuticals and therapeutics
No 86613157
No Service Mark
No 2003080-0851
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 01st Jul 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 01st Jul 2019 | ABANDONMENT - NO USE STATEMENT FILED |
| 30th Nov 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 29th Nov 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 29th Nov 2018 | EXTENSION 5 GRANTED |
| 19th Nov 2018 | TEAS EXTENSION RECEIVED |
| 19th Nov 2018 | EXTENSION 5 FILED |
| 15th May 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 11th May 2018 | EXTENSION 4 FILED |
| 11th May 2018 | TEAS EXTENSION RECEIVED |
